A tribunal has ruled that Aramark cannot attempt to appeal a decision by the competition regulator to block its merger with a Scottish rival, saying the U.S. hospitality company's lawyers filed its appeal hours after the deadline with no reasonable excuse.
A tribunal has ruled that Aramark cannot attempt to appeal a decision by the competition regulator to block its merger with a Scottish rival, saying the U.S. hospitality company's lawyers filed its appeal hours after the deadline with no reasonable excuse.
GlaxoSmithKline has agreed to license its experimental liver disease drug linerixibat to Italian pharmaceutical company Alfasigma, which focuses on serious liver conditions, for up to $690 million.
Canada Life said Tuesday it has completed a £105 million ($141.4 million) full-scheme buy-in with a U.K. pension scheme sponsored by an unidentified industrial company, securing benefits for more than 1,800 members.
Videndum PLC said Tuesday that it is planning to raise £85 million ($114 million) in equity as part of a broader plan of refinancing arrangements with its lenders to strengthen its finances, including debt repayments and restructuring, to avoid going under.
Faron Pharmaceuticals said Tuesday it has launched a program to raise approximately €40 million ($46.5 million) to support clinical trials for its main cancer drug candidate and finance its operating costs into late 2027.
Costain Group PLC on Tuesday started the first half of a share repurchase program worth up to £20 million ($27 million), a move expected to lower the infrastructure specialist's share capital.
Sabre Insurance Group PLC said Tuesday that it will reward shareholders with another share repurchase program worth up to £5 million ($6.7 million) as it reported lower premiums.
The European Commission’s recent historic decision to grant full adequacy status to Brazil for personal data transfers removes a significant compliance burden for organizations and offers an opportunity to simplify transfer mechanisms, positioning Brazil as a major gateway for EU-Latin America data flows, say lawyers at Gibson Dunn.
